Application of Technologies for Interactome Network Analyses of Cancer Mutations

癌症突变相互作用组网络分析技术的应用

• 批准号: 7364880
• 负责人: Marc Vidal
• 金额: $ 60.26万
• 依托单位: DANA-FARBER CANCER INST
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-06-05 至 2011-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7364880
• 关键词: 2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazole; Address; Alleles; Amino Acids; Attention; Biological; Biological Process; Cancer Etiology; Cells; Classification; Complex; DNA-Protein Interaction; Data Set; Development; Disease; Drug effect disorder; Generations; Genes; Genome; Goals; Human; Light; Malignant Neoplasms; Maps; Mediating; Medicine; Modeling; Molecular; Molecular Biology; Molecular Models; Molecular Profiling; Mutate; Mutation; Numbers; Oncogenes; Pathogenesis; Property; Proteins; Proteome; Proteomics; System; Systems Analysis; Systems Biology; Technology; Thinking; Time; Tumor Suppressor Genes; cancer genome; concept; cost; functional genomics; genome sequencing; in vivo; innovative technologies; interest; neoplastic cell; network models; new technology; novel; novel therapeutics; predictive modeling; protein protein interaction; research study; success; tumorigenesis

DESCRIPTION (provided by applicant): The molecular mechanisms underlying cancer have been mainly studied one or a few "cancer genes" at-a-time. However, it is thought that combinations of mutated or aberrantly expressed tumor suppressor- and oncogenes may be responsible for advancing cells through most steps of tumorigenesis. Many cancer causing mutations are disrupting interactions and these alterations are often directly related to the mechanism of pathogenesis. Thus, altered protein-protein interactions may directly point to a mechanism for cancerogenesis. More importantly, since it is becoming increasingly clear that genes and their products interact in complex biological networks with local and global properties, it is possible that perturbations of these networks contribute to cancer formation. We propose that a further understanding of the mechanisms involved in cancer, and the development of new therapeutic strategies, can be gained by i) studying genes and their products in the context of the molecular networks in which they function, and ii) investigating how such networks are altered in tumor cells compared to their unaffected counterparts. In addition to the information available from several drafts of the human genome sequence, genome- wide experimental strategies have been developed that will help us understand the effects of cancer mutations in the context of molecular networks: i) protein-protein and DNA-protein interaction networks or "interactome" networks are being mapped at an increasing pace, producing datasets with ever increasing quality and decreasing costs, and ii) large numbers of cancer-associated mutations are being discovered in the context of the human cancer genome project. Here we propose to develop a genome-wide application for a new technology platform that we have recently initiated to systematically study the effects of cancer-associated mutations on the physical and functional interactions mediated by the products encoded by cancer genes in the context of global interactome models. Our specific aims are to apply our experimental and computational technology platforms to: i) clone large numbers of cancer-associated missense or single amino acid change (SAC) alleles, ii) identify and characterize the interaction properties of large numbers of SAC alleles, iii) analyze the effects of SAC alleles on the local and global properties of interactome networks.

描述（申请人提供）：癌症的分子机制主要是一次研究一个或几个“癌症基因”。然而，人们认为突变或异常表达的肿瘤抑制基因和癌基因的组合可能在肿瘤发生的大多数步骤中推动细胞前进。许多致癌突变破坏了相互作用，这些改变往往与发病机制直接相关。因此，蛋白质-蛋白质相互作用的改变可能直接指向癌症发生的机制。更重要的是，由于基因及其产物在具有局部和全局特性的复杂生物网络中相互作用变得越来越清楚，这些网络的扰动可能有助于癌症的形成。我们建议进一步了解癌症的机制，并开发新的治疗策略，可以通过i)研究基因及其产物在其功能的分子网络背景下，ii)研究这些网络在肿瘤细胞中与未受影响的细胞相比是如何改变的。除了从人类基因组序列的几份草稿中获得的信息外，全基因组实验策略已经开发出来，这将有助于我们理解在分子网络背景下癌症突变的影响：1)蛋白质-蛋白质和dna -蛋白质相互作用网络或“相互作用组”网络正以越来越快的速度被绘制出来，产生的数据集质量不断提高，成本不断降低；2)在人类癌症基因组计划的背景下，大量癌症相关突变正在被发现。在这里，我们建议开发一个全基因组应用的新技术平台，我们最近开始系统地研究癌症相关突变对全球相互作用模型背景下由癌症基因编码的产物介导的物理和功能相互作用的影响。我们的具体目标是应用我们的实验和计算技术平台：i)克隆大量与癌症相关的错义或单氨基酸变化（SAC）等位基因，ii)鉴定和表征大量SAC等位基因的相互作用特性，iii)分析SAC等位基因对相互作用组网络的局部和全局特性的影响。